Stock DNA
Pharmaceuticals & Biotechnology
CNY 6,419 Million (Mid Cap)
181.00
NA
0.14%
-0.22
11.14%
20.14
Revenue and Profits:
Net Sales:
76 Million
(Quarterly Results - Jun 2025)
Net Profit:
10 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.76%
0%
-5.76%
6 Months
-13.88%
0%
-13.88%
1 Year
99.45%
0%
99.45%
2 Years
176.92%
0%
176.92%
3 Years
72.66%
0%
72.66%
4 Years
88.98%
0%
88.98%
5 Years
143.24%
0%
143.24%
Shanghai Jiaoda Onlly Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News

Shanghai Jiaoda Onlly Hits Day Low of CNY 8.25 Amid Price Pressure
Shanghai Jiaoda Onlly Co. experienced a decline on October 30, 2025, contrasting with the overall market's modest gain. Despite recent setbacks, the company has shown strong annual growth and consistent profitability over the past four quarters, although its management efficiency could improve.
Read More Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.18%
EBIT Growth (5y)
40.04%
EBIT to Interest (avg)
-3.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
0.84
Tax Ratio
6.05%
Dividend Payout Ratio
30.03%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.96%
ROE (avg)
5.10%
Valuation key factors
Factor
Value
P/E Ratio
181
Industry P/E
Price to Book Value
20.14
EV to EBIT
123.06
EV to EBITDA
58.96
EV to Capital Employed
25.59
EV to Sales
20.41
PEG Ratio
0.33
Dividend Yield
0.14%
ROCE (Latest)
20.79%
ROE (Latest)
11.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
76.20
72.40
5.25%
Operating Profit (PBDIT) excl Other Income
21.50
10.20
110.78%
Interest
2.00
2.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
10.10
-5.50
283.64%
Operating Profit Margin (Excl OI)
102.70%
-48.10%
15.08%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 5.25% vs -16.78% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 283.64% vs -121.57% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
320.20
291.90
9.70%
Operating Profit (PBDIT) excl Other Income
69.30
30.30
128.71%
Interest
10.30
13.80
-25.36%
Exceptional Items
37.00
-4.10
1,002.44%
Consolidate Net Profit
35.60
-31.90
211.60%
Operating Profit Margin (Excl OI)
51.70%
-63.20%
11.49%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 9.70% vs -21.57% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 211.60% vs 93.56% in Dec 2023
About Shanghai Jiaoda Onlly Co., Ltd. 
Shanghai Jiaoda Onlly Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






